story of the week
Intensification of Androgen Blockade in Men With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)
J. Clin. Oncol 2024 Jan 23;[EPub Ahead of Print], R Aggarwal, G Heller, DW Hillman, H Xiao, J Picus, ME Taplin, T Dorff, L Appleman, D Weckstein, A Patnaik, A Bryce, D Shevrin, J Mohler, D Anderson, A Rao, S Tagawa, A Tan, S Halabi, K Dooley, P O'Brien, R Chen, CJ Ryan, SE Eggener, MJ MorrisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.